# Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

> **NCT07281781** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 10 (estimated)

## Conditions studied

- Myelofibrosis
- Myelofibrosis; Anemia

## Interventions

- **DRUG:** Nelfinavir

## Key facts

- **NCT ID:** NCT07281781
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281781, "Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07281781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*